Bliss GVS Pharma

Bliss GVS Pharma Subsidiary Secures UK MHRA Approval for Mesalazine 1g Suppositories

Bliss GVS Pharma's UK arm Asterisk Lifesciences receives MHRA marketing authorisation for Mesalazine 1g Suppositories, marking a major regulated market expansion.

Bliss GVS Pharma · 4 Nov 2026, 5:11 PM IST